Atherectomy Devices Market By Product (Directional Atherectomy Devices, Rotational Atherectomy Devices, Orbital Atherectomy Devices, Others), By End User (Hospitals, Ambulatory surgery centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Atherectomy Devices Market

Atherosclerosis is a disease in which plaque builds up inside the arteries. Plaque is made up of fat, cholesterol, calcium, and other substances found in the blood. Over time, plaque can harden and narrow the arteries, which can limit the flow of oxygen-rich blood to the organs and tissues throughout the body. Atherectomy devices are medical tools used to remove these plaque buildups from the walls of arteries. 

Key factors driving the growth of the atherectomy devices market is increase in prevalence of peripheral artery disease, growth in geriatric population, and surge in demand of minimally invasive procedures. Peripheral artery disease (PAD) occurs when the arteries that supply blood to these areas become narrowed or blocked due to a buildup of plaque. The increasing prevalence of PAD is expected to act as a major driver for the atherectomy devices market. According to 2021 report by National Heart Lung and Blood Institute, nearly 10 million people age 40 and older in the United States have PAD. National Heart Lung and Blood Institute provides training, and education programs to promote the prevention and treatment of heart, lung, and blood diseases. 

Furthermore, the growing geriatric population is expected to act as a driver for the atherectomy devices. The geriatric population, which refers to individuals over the age of 65, is growing rapidly around the world. As this population continues to grow, there is an increased prevalence of age-related health issues, including peripheral artery disease (PAD). According to 2022 report by National Library of Medicine, a biomedical library that serves as national information resource for medical education, research, and service activities of federal and private agencies, PAD affects over 200 million adults worldwide and the incidence of PAD increases to as high as 20% in people over the age of 70. 

The market also offers growth opportunities to the key players in the market. Technological advancement in atherectomy devices can create significant growth opportunities for the market. Atherectomy devices have become increasingly sophisticated and effective in recent years, with the development of new technologies such as laser atherectomy and image-guided technology. Laser atherectomy devices typically consist of a catheter with a laser fiber at the tip, which is inserted into the blocked artery. The laser emits pulses of energy that vaporize and break up the plaque, which can then be removed through suction or other techniques. Furthermore, image-guided technology  provides  real-time visualization using various imaging modalities such as fluoroscopy, intravascular ultrasound (IVUS), optical coherence tomography (OCT), or magnetic resonance imaging (MRI). By integrating the imaging data with the atherectomy device's position and operation, the physician can achieve more precise and targeted removal of the plaque while minimizing the risk of damaging healthy tissues or causing complications. These advances are likely to increase demand for atherectomy devices as physicians seek out more effective treatment options. 

Furthermore, growing awareness of the benefits of atherectomy is expected to present significant growth opportunity for the market. For instance, as more physicians become familiar with atherectomy devices and their benefits, demand for these devices is likely to increase. Atherectomy is a minimally invasive procedure that can be performed on an outpatient basis, which can be attractive to patients who are looking to avoid more invasive surgeries. 

The atherectomy devices market is segmented on the basis of product, end user, and region. On the basis of product, the atherectomy devices market is classified into directional atherectomy devices, rotational atherectomy devices, orbital atherectomy devices, and others. By end user, it is fragmented into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Major key players that operate in the global atherectomy devices market include Medtronic plc, Koninklijke Philips N.V., Boston Scientific Corporation, Cardiovascular Systems, Inc., Becton, Dickinson and Company, AngioDynamics Inc., Rex medical, Nipro Corporation, Invamed medical, and Avinger Inc. 

Key Market Insights  

By product, the rotational atherectomy devices was highest contributor to the market in 2021 and is estimated to reach $726.75 million by 2031, with a CAGR of 10.2%. However, the directional atherectomy devices is anticipated to grow at the highest CAGR during the forecasted period. 

By end user, the hospitals were highest contributor to the market in 2021. However, the Ambulatory surgery centers is anticipated to grow at the highest CAGR of 10.9% during the forecasted period.  

Region wise, North America generated the largest revenue in 2021. However, Asia-Pacific is anticipated to grow at the highest CAGR of 11.9% during the forecasted period. 

Overview

The global atherectomy devices market was valued at $ 787.12 million in 2021 and is projected to reach $ 2111.97 million by 2031, registering a CAGR of 10.5% from 2022 to 2031.  

Atherectomy devices are medical devices used to remove plaque buildup in arteries, particularly in cases of atherosclerosis. Atherosclerosis is a disease of the arteries in which fatty deposits, known as plaques, build up on the inner walls of the arteries, leading to their narrowing and hardening. 

Atherectomy devices are medical devices used to remove atherosclerotic plaque from the walls of arteries. Atherectomy devices are often used in conjunction with other treatments for peripheral artery disease (PAD), such as balloon angioplasty or stenting, to improve blood flow, and alleviate symptoms. They are typically performed in a hospital or outpatient setting and are usually done under local anesthesia. Like all medical procedures, atherectomy carries some risks, including bleeding, infection, and damage to the artery. However, with proper patient selection and technique, atherectomy can be a safe and effective treatment option for peripheral artery disease (PAD). 

The surge in demand for atherectomy devices is due to rise in incidence of cardiovascular diseases, such as atherosclerosis, Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD). Atherosclerosis, which is a condition characterized by the buildup of plaque inside the arteries, leading to the narrowing and hardening of the arteries. This can result in reduced blood flow to vital organs such as the heart and brain, which can lead to serious health problems such as heart attacks and strokes. Furthermore, the prevalence of atherosclerosis has increased in recent years due to various factors, including changes in lifestyle and an aging population. In 2021, according to a report by American Heart Association, atherosclerotic lower extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. 

Furthermore, the elderly population is at a higher risk of developing cardiovascular diseases and other related conditions, such as diabetes and hypertension due to the fact that blood vessels lose elasticity with age, becoming stiffer and less able to expand and contract as needed to regulate blood pressure. In addition, some elderly individuals may have a genetic predisposition to cardiovascular disease (CVDs), such as a family history of heart disease or stroke. Moreover, increase in demand for minimally invasive procedures due to reduced pain, shorter hospital stays, and faster recovery times is expected to drive the market growth during the forecast period. 

In addition, the rise in healthcare expenditure in both developed and developing countries drives demand for atherectomy devices, as healthcare providers seek to offer the latest and most effective treatments to their patients. Thus, these were the major factors that contribute to the growth of the atherectomy devices market. However, factors such as high cost of atherectomy treatment, limited availability of skilled healthcare professionals, and risk of complications might restrain the growth of the atherectomy devices market. 

The atherectomy devices market is segmented into type, end user, and region. By type, the market is categorized into directional atherectomy devices, rotational atherectomy devices, orbital atherectomy devices, and others. By end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Major key players that operate in the global atherectomy devices market include Medtronic plc, Koninklijke Philips N.V., Boston Scientific Corporation, Cardiovascular Systems, Inc., Becton, Dickinson and Company, AngioDynamics Inc., Rex medical, Nipro Corporation, Invamed medical, and Avinger Inc.

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the atherectomy devices market analysis from 2021 to 2031 to identify the prevailing atherectomy devices market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the atherectomy devices market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global atherectomy devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ Avinger Inc

Scope of Atherectomy Devices Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research Methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Bargaining power of suppliers

3.3.2. Bargaining power of buyers

3.3.3. Threat of substitutes

3.3.4. Threat of new entrants

3.3.5. Intensity of rivalry

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increasing prevalence of peripheral artery disease (PAD)

3.4.1.2. Growth in geriatric population

3.4.1.3. Surge in demand for minimally invasive procedures

3.4.2. Restraints

3.4.2.1. Limited availability of skilled healthcare professionals

3.4.3. Opportunities

3.4.3.1. Technological advancement in Atherectomy devices

3.5. COVID-19 Impact Analysis on the market

4.1. Overview

4.1.1. Market size and forecast

4.2. Directional Atherectomy Devices

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.3. Rotational Atherectomy Devices

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

4.4. Orbital Atherectomy Devices

4.4.1. Key market trends, growth factors and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market share analysis by country

4.5. Others

4.5.1. Key market trends, growth factors and opportunities

4.5.2. Market size and forecast, by region

4.5.3. Market share analysis by country

5.1. Overview

5.1.1. Market size and forecast

5.2. Hospitals

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Ambulatory surgery centers

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

5.4. Others

5.4.1. Key market trends, growth factors and opportunities

5.4.2. Market size and forecast, by region

5.4.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast By Region

6.2. North America

6.2.1. Key trends and opportunities

6.2.2. Market size and forecast, by Product

6.2.3. Market size and forecast, by End User

6.2.4. Market size and forecast, by country

6.2.4.1. U.S.

6.2.4.1.1. Key market trends, growth factors and opportunities

6.2.4.1.2. Market size and forecast, by Product

6.2.4.1.3. Market size and forecast, by End User

6.2.4.2. Canada

6.2.4.2.1. Key market trends, growth factors and opportunities

6.2.4.2.2. Market size and forecast, by Product

6.2.4.2.3. Market size and forecast, by End User

6.2.4.3. Mexico

6.2.4.3.1. Key market trends, growth factors and opportunities

6.2.4.3.2. Market size and forecast, by Product

6.2.4.3.3. Market size and forecast, by End User

6.3. Europe

6.3.1. Key trends and opportunities

6.3.2. Market size and forecast, by Product

6.3.3. Market size and forecast, by End User

6.3.4. Market size and forecast, by country

6.3.4.1. Germany

6.3.4.1.1. Key market trends, growth factors and opportunities

6.3.4.1.2. Market size and forecast, by Product

6.3.4.1.3. Market size and forecast, by End User

6.3.4.2. France

6.3.4.2.1. Key market trends, growth factors and opportunities

6.3.4.2.2. Market size and forecast, by Product

6.3.4.2.3. Market size and forecast, by End User

6.3.4.3. UK

6.3.4.3.1. Key market trends, growth factors and opportunities

6.3.4.3.2. Market size and forecast, by Product

6.3.4.3.3. Market size and forecast, by End User

6.3.4.4. Italy

6.3.4.4.1. Key market trends, growth factors and opportunities

6.3.4.4.2. Market size and forecast, by Product

6.3.4.4.3. Market size and forecast, by End User

6.3.4.5. Spain

6.3.4.5.1. Key market trends, growth factors and opportunities

6.3.4.5.2. Market size and forecast, by Product

6.3.4.5.3. Market size and forecast, by End User

6.3.4.6. Rest of Europe

6.3.4.6.1. Key market trends, growth factors and opportunities

6.3.4.6.2. Market size and forecast, by Product

6.3.4.6.3. Market size and forecast, by End User

6.4. Asia-Pacific

6.4.1. Key trends and opportunities

6.4.2. Market size and forecast, by Product

6.4.3. Market size and forecast, by End User

6.4.4. Market size and forecast, by country

6.4.4.1. China

6.4.4.1.1. Key market trends, growth factors and opportunities

6.4.4.1.2. Market size and forecast, by Product

6.4.4.1.3. Market size and forecast, by End User

6.4.4.2. Japan

6.4.4.2.1. Key market trends, growth factors and opportunities

6.4.4.2.2. Market size and forecast, by Product

6.4.4.2.3. Market size and forecast, by End User

6.4.4.3. India

6.4.4.3.1. Key market trends, growth factors and opportunities

6.4.4.3.2. Market size and forecast, by Product

6.4.4.3.3. Market size and forecast, by End User

6.4.4.4. Australia

6.4.4.4.1. Key market trends, growth factors and opportunities

6.4.4.4.2. Market size and forecast, by Product

6.4.4.4.3. Market size and forecast, by End User

6.4.4.5. South Korea

6.4.4.5.1. Key market trends, growth factors and opportunities

6.4.4.5.2. Market size and forecast, by Product

6.4.4.5.3. Market size and forecast, by End User

6.4.4.6. Rest of Asia-Pacific

6.4.4.6.1. Key market trends, growth factors and opportunities

6.4.4.6.2. Market size and forecast, by Product

6.4.4.6.3. Market size and forecast, by End User

6.5. LAMEA

6.5.1. Key trends and opportunities

6.5.2. Market size and forecast, by Product

6.5.3. Market size and forecast, by End User

6.5.4. Market size and forecast, by country

6.5.4.1. Brazil

6.5.4.1.1. Key market trends, growth factors and opportunities

6.5.4.1.2. Market size and forecast, by Product

6.5.4.1.3. Market size and forecast, by End User

6.5.4.2. Saudi Arabia

6.5.4.2.1. Key market trends, growth factors and opportunities

6.5.4.2.2. Market size and forecast, by Product

6.5.4.2.3. Market size and forecast, by End User

6.5.4.3. South Africa

6.5.4.3.1. Key market trends, growth factors and opportunities

6.5.4.3.2. Market size and forecast, by Product

6.5.4.3.3. Market size and forecast, by End User

6.5.4.4. Rest of LAMEA

6.5.4.4.1. Key market trends, growth factors and opportunities

6.5.4.4.2. Market size and forecast, by Product

6.5.4.4.3. Market size and forecast, by End User

7.1. Introduction

7.2. Top winning strategies

7.3. Product Mapping of Top 10 Player

7.4. Competitive Dashboard

7.5. Competitive Heatmap

7.6. Top player positioning, 2021

8.1. Medtronic plc

8.1.1. Company overview

8.1.2. Key Executives

8.1.3. Company snapshot

8.1.4. Operating business segments

8.1.5. Product portfolio

8.1.6. Business performance

8.2. Koninklijke Philips N.V.

8.2.1. Company overview

8.2.2. Key Executives

8.2.3. Company snapshot

8.2.4. Operating business segments

8.2.5. Product portfolio

8.2.6. Business performance

8.3. Boston Scientific Corporation

8.3.1. Company overview

8.3.2. Key Executives

8.3.3. Company snapshot

8.3.4. Operating business segments

8.3.5. Product portfolio

8.3.6. Business performance

8.4. Cardiovascular Systems, Inc.

8.4.1. Company overview

8.4.2. Key Executives

8.4.3. Company snapshot

8.4.4. Operating business segments

8.4.5. Product portfolio

8.4.6. Business performance

8.4.7. Key strategic moves and developments

8.5. Becton, Dickinson and Company

8.5.1. Company overview

8.5.2. Key Executives

8.5.3. Company snapshot

8.5.4. Operating business segments

8.5.5. Product portfolio

8.5.6. Business performance

8.5.7. Key strategic moves and developments

8.6. AngioDynamics Inc.

8.6.1. Company overview

8.6.2. Key Executives

8.6.3. Company snapshot

8.6.4. Operating business segments

8.6.5. Product portfolio

8.6.6. Business performance

8.6.7. Key strategic moves and developments

8.7. Rex medical

8.7.1. Company overview

8.7.2. Key Executives

8.7.3. Company snapshot

8.7.4. Operating business segments

8.7.5. Product portfolio

8.8. Nipro Corporation

8.8.1. Company overview

8.8.2. Key Executives

8.8.3. Company snapshot

8.8.4. Operating business segments

8.8.5. Product portfolio

8.8.6. Business performance

8.9. Invamed medical

8.9.1. Company overview

8.9.2. Key Executives

8.9.3. Company snapshot

8.9.4. Operating business segments

8.9.5. Product portfolio

8.10. Avinger Inc.

8.10.1. Company overview

8.10.2. Key Executives

8.10.3. Company snapshot

8.10.4. Operating business segments

8.10.5. Product portfolio

8.10.6. Business performanc

LIST OF TABLES

TABLE 01. GLOBAL ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 02. ATHERECTOMY DEVICES MARKET FOR DIRECTIONAL ATHERECTOMY DEVICES, BY REGION, 2021-2031 ($MILLION)

TABLE 03. ATHERECTOMY DEVICES MARKET FOR ROTATIONAL ATHERECTOMY DEVICES, BY REGION, 2021-2031 ($MILLION)

TABLE 04. ATHERECTOMY DEVICES MARKET FOR ORBITAL ATHERECTOMY DEVICES, BY REGION, 2021-2031 ($MILLION)

TABLE 05. ATHERECTOMY DEVICES MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 06. GLOBAL ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 07. ATHERECTOMY DEVICES MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)

TABLE 08. ATHERECTOMY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2021-2031 ($MILLION)

TABLE 09. ATHERECTOMY DEVICES MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 10. ATHERECTOMY DEVICES MARKET, BY REGION, 2021-2031 ($MILLION)

TABLE 11. NORTH AMERICA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 12. NORTH AMERICA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 13. NORTH AMERICA ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 14. U.S. ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 15. U.S. ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 16. CANADA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 17. CANADA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 18. MEXICO ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 19. MEXICO ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 20. EUROPE ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 21. EUROPE ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 22. EUROPE ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 23. GERMANY ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 24. GERMANY ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 25. FRANCE ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 26. FRANCE ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 27. UK ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 28. UK ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 29. ITALY ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 30. ITALY ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 31. SPAIN ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 32. SPAIN ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 33. REST OF EUROPE ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 34. REST OF EUROPE ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 35. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 36. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 37. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 38. CHINA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 39. CHINA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 40. JAPAN ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 41. JAPAN ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 42. INDIA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 43. INDIA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 44. AUSTRALIA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 45. AUSTRALIA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 46. SOUTH KOREA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 47. SOUTH KOREA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 48. REST OF ASIA-PACIFIC ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 49. REST OF ASIA-PACIFIC ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 50. LAMEA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 51. LAMEA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 52. LAMEA ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 53. BRAZIL ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 54. BRAZIL ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 55. SAUDI ARABIA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 56. SAUDI ARABIA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 57. SOUTH AFRICA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 58. SOUTH AFRICA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 59. REST OF LAMEA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 60. REST OF LAMEA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 61. MEDTRONIC PLC: KEY EXECUTIVES

TABLE 62. MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 63. MEDTRONIC PLC: PRODUCT SEGMENTS

TABLE 64. MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 65. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES

TABLE 66. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT

TABLE 67. KONINKLIJKE PHILIPS N.V.: PRODUCT SEGMENTS

TABLE 68. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO

TABLE 69. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES

TABLE 70. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT

TABLE 71. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS

TABLE 72. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO

TABLE 73. CARDIOVASCULAR SYSTEMS, INC.: KEY EXECUTIVES

TABLE 74. CARDIOVASCULAR SYSTEMS, INC.: COMPANY SNAPSHOT

TABLE 75. CARDIOVASCULAR SYSTEMS, INC.: PRODUCT SEGMENTS

TABLE 76. CARDIOVASCULAR SYSTEMS, INC.: PRODUCT PORTFOLIO

TABLE 77. CARDIOVASCULAR SYSTEMS, INC.: KEY STRATERGIES

TABLE 78. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES

TABLE 79. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT

TABLE 80. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS

TABLE 81. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO

TABLE 82. BECTON, DICKINSON AND COMPANY: KEY STRATERGIES

TABLE 83. ANGIODYNAMICS INC.: KEY EXECUTIVES

TABLE 84. ANGIODYNAMICS INC.: COMPANY SNAPSHOT

TABLE 85. ANGIODYNAMICS INC.: PRODUCT SEGMENTS

TABLE 86. ANGIODYNAMICS INC.: PRODUCT PORTFOLIO

TABLE 87. ANGIODYNAMICS INC.: KEY STRATERGIES

TABLE 88. REX MEDICAL: KEY EXECUTIVES

TABLE 89. REX MEDICAL: COMPANY SNAPSHOT

TABLE 90. REX MEDICAL: PRODUCT SEGMENTS

TABLE 91. REX MEDICAL: PRODUCT PORTFOLIO

TABLE 92. NIPRO CORPORATION: KEY EXECUTIVES

TABLE 93. NIPRO CORPORATION: COMPANY SNAPSHOT

TABLE 94. NIPRO CORPORATION: PRODUCT SEGMENTS

TABLE 95. NIPRO CORPORATION: PRODUCT PORTFOLIO

TABLE 96. INVAMED MEDICAL: KEY EXECUTIVES

TABLE 97. INVAMED MEDICAL: COMPANY SNAPSHOT

TABLE 98. INVAMED MEDICAL: PRODUCT SEGMENTS

TABLE 99. INVAMED MEDICAL: PRODUCT PORTFOLIO

TABLE 100. AVINGER INC.: KEY EXECUTIVES

TABLE 101. AVINGER INC.: COMPANY SNAPSHOT

TABLE 102. AVINGER INC.: PRODUCT SEGMENTS

TABLE 103. AVINGER INC.: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01. ATHERECTOMY DEVICES MARKET, 2021-2031

FIGURE 02. SEGMENTATION OF ATHERECTOMY DEVICES MARKET, 2021-2031

FIGURE 03. TOP INVESTMENT POCKETS IN ATHERECTOMY DEVICES MARKET (2022-2031)

FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS

FIGURE 05. LOW BARGAINING POWER OF BUYERS

FIGURE 06. LOW THREAT OF SUBSTITUTES

FIGURE 07. LOW THREAT OF NEW ENTRANTS

FIGURE 08. LOW INTENSITY OF RIVALRY

FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALATHERECTOMY DEVICES MARKET

FIGURE 10. ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021(%)

FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ATHERECTOMY DEVICES MARKET FOR DIRECTIONAL ATHERECTOMY DEVICES, BY COUNTRY 2021 AND 2031(%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ATHERECTOMY DEVICES MARKET FOR ROTATIONAL ATHERECTOMY DEVICES, BY COUNTRY 2021 AND 2031(%)

FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ATHERECTOMY DEVICES MARKET FOR ORBITAL ATHERECTOMY DEVICES, BY COUNTRY 2021 AND 2031(%)

FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ATHERECTOMY DEVICES MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)

FIGURE 15. ATHERECTOMY DEVICES MARKET, BY END USER, 2021(%)

FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ATHERECTOMY DEVICES MARKET FOR HOSPITALS, BY COUNTRY 2021 AND 2031(%)

FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ATHERECTOMY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY 2021 AND 2031(%)

FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ATHERECTOMY DEVICES MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)

FIGURE 19. ATHERECTOMY DEVICES MARKET BY REGION, 2021

FIGURE 20. U.S. ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 21. CANADA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 22. MEXICO ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 23. GERMANY ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 24. FRANCE ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 25. UK ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 26. ITALY ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 27. SPAIN ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 28. REST OF EUROPE ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 29. CHINA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 30. JAPAN ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 31. INDIA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 32. AUSTRALIA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 33. SOUTH KOREA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 34. REST OF ASIA-PACIFIC ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 35. BRAZIL ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 36. SAUDI ARABIA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 37. SOUTH AFRICA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 38. REST OF LAMEA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)

FIGURE 39. TOP WINNING STRATEGIES, BY YEAR

FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 42. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 43. COMPETITIVE DASHBOARD

FIGURE 44. COMPETITIVE HEATMAP: ATHERECTOMY DEVICES MARKET

FIGURE 45. TOP PLAYER POSITIONING, 2021

FIGURE 46. MEDTRONIC PLC: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 47. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 48. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 49. KONINKLIJKE PHILIPS N.V.: NET SALES, 2020-2022 ($MILLION)

FIGURE 50. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 51. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 52. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2020-2022 ($MILLION)

FIGURE 53. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 54. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 55. CARDIOVASCULAR SYSTEMS, INC.: NET SALES, 2020-2022 ($MILLION)

FIGURE 56. CARDIOVASCULAR SYSTEMS, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 57. CARDIOVASCULAR SYSTEMS, INC.: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 58. BECTON, DICKINSON AND COMPANY: NET REVENUE, 2020-2022 ($MILLION)

FIGURE 59. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 60. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 61. ANGIODYNAMICS INC.: NET SALES, 2020-2022 ($MILLION)

FIGURE 62. ANGIODYNAMICS INC.: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 63. ANGIODYNAMICS INC.: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 64. NIPRO CORPORATION: NET SALES, 2020-2022 ($MILLION)

FIGURE 65. NIPRO CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 66. NIPRO CORPORATION: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 67. AVINGER INC.: NET SALES, 2019-2021 ($MILLION